Fenwick & West has advised CareDx, Inc.; Kahn Partners LLP has advised EuroBio Scientific S.A. CareDx, Inc. has entered into a definitive agreement to divest its...
CareDx Divests Lab Products Business to EuroBio Scientific for $170 Million
DigiCert Acquires Valimail to Enhance Digital Trust Offering
Fenwick & West has advised Valimail. Sidley has advised DigiCert. DigiCert, a leading global provider of digital trust solutions backed by Clearlake Capital Group, Crosspoint Capital...
Lyra Health Acquires Bend Health to Expand Pediatric Services
Fenwick & West has advised Lyra Health on the transaction. Lyra Health, a leading provider of mental health benefits for employers, has announced the acquisition of...
Formation Bio Enters Licensing Agreement with Sanofi for Gusacitinib
Fenwick has advised Formation Bio on the deal. Formation Bio, an AI-native drug development company, has entered into a licensing agreement with Sanofi, a French multinational...
GeneDX’s Acquisition of Fabric Genomics
Fenwick & West represented GeneDX in the transaction, and DLA Piper advised Fabric Genomics, Inc. GeneDX (Nasdaq: WGS), a company delivering improved health outcomes through genomic...
AbbVie’s $1.4 Billion Acquisition of Aliada Therapeutics
Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics. AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into...
Incyte’s $750 Million Acquisition of Escient Pharmaceuticals
Fenwick & West is advising Escient Pharmaceuticals on the transaction, and Covington & Burling is advising Incyte. Incyte (Nasdaq:INCY) announced the acquisition of Escient Pharmaceuticals (“Escient”). Incyte...
EditCo Bio and Telegraph Hill Partners’ Acquisition of Synthego’s Engineered Cell Solutions Business
Fenwick & West represented Synthego in the transaction. EditCo Bio, Inc. announced that it has launched its business with the acquisition of Synthego’s engineered cell solutions...
Veracyte’s Acquisition of C2i Genomics
Fenwick & West is representing Veracyte in the transaction, and Meitar is representing C2i Genomics. Veracyte, Inc. (Nasdaq: VCYT) announced it has entered into a definitive agreement...
Insight Enterprises’ Acquisition of SADA
Snell & Wilmer represented Insight Enterprises in the transaction, and Fenwick & West represented SADA. Insight Enterprises (NASDAQ:NSIT) announced it has completed the acquisition of SADA, a leading cloud...
Eli Lilly’s $2.4 Billion Pending Acquisition of DICE THerapeutics
Fenwick & West LLP represented DICE Therapeutics, Inc. in the transaction, while Kirkland & Ellis represented Eli Lilly and Company. Eli Lilly and Company (NYSE: LLY)...
Novartis AG’s Acquisition of Chinook Therapeutics
Fenwick & West LLP represented Chinook Therapeutics, Inc. on the transaction, while Hogan Lovells US LLP represented Novartis AG. Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company, announced...